Coating spray uses 'nanoworms' to kill COVID-19
Friday, 17 September, 2021
An antiviral surface coating technology developed at could provide an extra layer of protection against COVID-19 and the flu.
The water-based coating uses worm-like structures to attack the virus and could serve as a barrier against transmission on surfaces and face masks.
The coating was developed with as a joint research project, and was tested at the at , with research published in .
UQ鈥檚 Australian Institute for Bioengineering and Nanotechnology researcher Professor Michael Monteiro said, 鈥淲hen surgical masks were sprayed with these 鈥榥anoworms鈥, it resulted in complete inactivation of the Alpha variant of Sars-CoV-2 and influenza A.鈥
鈥淭hese polymer 鈥榥anoworms鈥 rupture the membrane of virus droplets transmitted through coughing, sneezing or saliva and damage their RNA,鈥 Professor Monteiro said.
鈥淭he chemistry involved is versatile, so the coating can be readily redesigned to target emerging viruses and aid in controlling future pandemics.鈥 Professor Monteiro said face masks would continue to be an important part of helping prevent or reduce community transmission of COVID-19.
鈥淎ntiviral coatings applied on mask surfaces could reduce infection and provide long-lasting control measures to eliminate both surface and aerosolised transmission,鈥 he said.
鈥淲e know that COVID-19 remains infectious for many hours or days on some surfaces, and provides a direct route to infection.
鈥淭herefore, there is greater emphasis on eliminating both surface and airborne transmission to complement vaccination of the population to stop the current pandemic.鈥
The coating is said to be environmentally friendly and water-based, and its synthesis aligns with manufacturing techniques used in the paint and coatings industry.听
听
Victoria's Q3 median ED wait times the lowest on record
Victoria's quarter three performance data (January–March) has shown improvement across...
Irregularities in a clinician's cases prompt 15-month lookback
St Vincent's 黑料吃瓜群网 Sydney has detailed a 15-month lookback review — prompted by...
Two researchers receive $899,000 in cardiovascular funding
In heart-related news this Heart Week (5–11 May), two University of Newcastle researchers...